Editas Medicine Inc - EDIT - stock price prediction, stock price target, analyst ratings from 15 analysts

Editas Medicine Inc has a share price target of US$ 5, revenue growth forecast of -26.9%, and profit growth estimate of 24.6% for FY25, based on top 15 analyst calls.